Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sedation regimens for flexible bronchoscopy in elderly patients
ChiCTR2400093378Phase 4Recruiting
- Sponsor
- Beilun District People's Hospital
- Start
- Jul 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, alfentanil, midazolam, propofol and sufentanil in bronchitis and pulmonary diseases (3 arms), sponsored by Beilun District People's Hospital. Primary endpoints: Neuropsychological test and Sleep assessment. Started Jul 2024; status: recruiting.
02
Drugs
remimazolamalfentanilmidazolampropofolsufentanil
03
Conditions
bronchitispulmonary diseases
Beyond the preview
Go deeper on ChiCTR2400093378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093378.